Abstract
Background The purpose of this study is to evaluate antimicrobial prescribing behaviors in the dermatology outpatient department.
Methods This multi-centered, cross-sectional study was conducted at dermatology outpatient department of three tertiary care hospitals in Chittagong division, Bangladesh during the period October, 2021 to April, 2022.
Results During the study period, 463 prescriptions were obtained. Over half of the participants were female (57%) and between the ages of 21 to 40 years. The majority of patients were diagnosed with eczema (19%), acne (17%), and scabies (15%). Most commonly prescribed antimicrobials was Azithromycin (22%), followed by Permethrin (16%) and Erythromycin (7%). In most cases, antimicrobials were recommended for more than two weeks (60%). Nearly half of the antimicrobials (53 %) were recommended as combination of systemic and topical route.
Conclusion Current study found that dermatologists frequently recommended broad-spectrum antimicrobials for extended periods of time, which may lead to antimicrobial resistance. There is a need for continuing medical education on the appropriate use of antimicrobials, which will result in the effective management of skin diseases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
no funding received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was taken from Institutional Review Board (IRB) of BGC Trust Medical College.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
yes
